165 related articles for article (PubMed ID: 1427628)
1. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
Aisaka K; Yoshida K; Mori H
Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
[TBL] [Abstract][Full Text] [Related]
2. Endocrine pathophysiology of luteal phase deficiency as assessed by GnRH/TRH stimulation tests performed in the early follicular and midluteal phases of the menstrual cycle.
Hayashi M; Suginami H; Taii S; Mori T
Endocr J; 1993 Jun; 40(3):297-309. PubMed ID: 7920882
[TBL] [Abstract][Full Text] [Related]
3. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
4. Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.
Soules MR; Clifton DK; Cohen NL; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1989 Oct; 69(4):813-20. PubMed ID: 2506215
[TBL] [Abstract][Full Text] [Related]
5. Prolactin secretion and corpus luteum function in women with luteal phase deficiency.
Soules MR; Bremner WJ; Steiner RA; Clifton DK
J Clin Endocrinol Metab; 1991 May; 72(5):986-92. PubMed ID: 2022718
[TBL] [Abstract][Full Text] [Related]
6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
7. Altered luteinizing hormone pulse frequency in early follicular phase of the menstrual cycle with luteal phase defect patients in women.
Suh BY; Betz G
Fertil Steril; 1993 Nov; 60(5):800-5. PubMed ID: 8224264
[TBL] [Abstract][Full Text] [Related]
8. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
[TBL] [Abstract][Full Text] [Related]
9. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season.
Ronkainen H
Fertil Steril; 1985 Dec; 44(6):755-9. PubMed ID: 3935485
[TBL] [Abstract][Full Text] [Related]
10. [Studies on prolactin secreting capacity in the ovulatory infertile patients with transient hyperprolactinemia].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):662-71. PubMed ID: 3089848
[TBL] [Abstract][Full Text] [Related]
11. [A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
Aisaka K; Kaneda S; Tsuzuki H; Toriya Y; Kokuho K; Tamechika S; Saitoh H; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):1017-27. PubMed ID: 8262272
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
[TBL] [Abstract][Full Text] [Related]
13. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
14. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
15. Impaired follicular growth and abnormal luteinizing hormone surge in luteal phase defect.
Ayabe T; Tsutsumi O; Momoeda M; Yano T; Mitsuhashi N; Taketani Y
Fertil Steril; 1994 Apr; 61(4):652-6. PubMed ID: 8150106
[TBL] [Abstract][Full Text] [Related]
16. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
[TBL] [Abstract][Full Text] [Related]
17. Transient hyperprolactinemia in infertile women with luteal phase deficiency.
Huang KE; Bonfiglio TA; Muechler EK
Obstet Gynecol; 1991 Oct; 78(4):651-5. PubMed ID: 1923170
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
19. LH pulses and the corpus luteum: the luteal phase deficiency LPD).
Wuttke W; Pitzel L; Seidlová-Wuttke D; Hinney B
Vitam Horm; 2001; 63():131-58. PubMed ID: 11358113
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine versus progesterone therapy for infertility related to luteal phase defects in hyperprolactinemic patients.
Check JH; Wu CH; Adelson HG
Int J Fertil; 1989; 34(3):209-14. PubMed ID: 2567717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
